Search results
Feb 6, 2024 · Joel P. Schneider, Ph.D. Senior Investigator. Chemical Biology Laboratory. NCI/CCR. View Site. Building 376, Room 104. Frederick, MD 21702-1201. 301-846-5954. Joel.Schneider@ nih.gov. Research Topics. Our group develops novel materials for use in the delivery of therapeutics and as antibacterial agents.
Chemical Biology Laboratory. Senior Investigator. Head, Peptide Design and Materials Section. CCR Deputy Director. RESEARCH SUMMARY. The Schneider group designs and characterizes novel materials for use in drug delivery, the delivery of cells, and antibacterial therapy. Areas of Expertise. Cancer Drug Discovery. Soft Materials. Drug Delivery.
Joel Schneider, United States Magistrate Judge (Ret.), serves as Of Counsel in Montgomery McCracken’s Litigation Department. Judge Schneider served as United States Magistrate Judge in the District of New Jersey for 14 years.
Articles 1–20. National Cancer Institute - Cited by 16,468 - soft materials - drug delivery - self-assembly - cell-penetrating peptides - peptide design synthesis & characterization.
Aug 18, 2020 · Joel Schneider. Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA-Peptide Nanoparticles toward Treating Mesothelioma. Advanced materials (Deerfield Beach, Fla.) 2024-03-26 | Journal article | Author. DOI: 10.1002/adma.202314367. PMID: 38532642. Contributors : Anderson CF; Singh A; Stephens T; Hoang CD; Joel Schneider.
People also ask
What does Dr Schneider do?
What does the Schneider group do?
Who is Judge Schneider?
Where did Dr Schneider go to college?
Mar 1, 2016 · Herein, we describe an intrinsically disordered peptide (CLIP6) that exclusively employs non-endosomal mechanisms to cross cellular membranes, while being remarkably biocompatible and serum-stable.